Leukapheresis Market CAGR is expected to be 7.5% during the forecast period and the market size is expected to reach nearly US$ 109.13 Bn. by 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is a specific type of apheresis, the more general term for separating out one particular constituent of blood and returning the remaining part to the circulation. Rising incidence and prevalence of leukemia, growing demand for leukopaks, and the increasing number of blood donations would drive the market growth rate for leukapheresis. However, it is the high cost of leukopaks and therapeutic leukapheresis, complications associated with therapeutic leukapheresis and the stringent regulations for leukocyte donor recruitment that may hamper the market growth of leukapheresis. Leukapheresis market is segmented by type, application, end user, and region. Among application, the research application segment market accounted for the xx% share in 2022 due to increasing adoption of leukapheresis for the isolation of WBCs and development of cell-based immunotherapies. Among regions, North America and Europe are expected to hold a xx% market share during the forecast period due to increasing the number of blood donations, rising incidence, and prevalence of leukaemia and growing demand for leukopaks in clinical research. The Asia Pacific is expected to grow at the xx% CAGR during the forecast period due increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the presence of leading pharma and biotech companies, and improvement in healthcare access. The production players focus on mergers and collaborations, strategic partnerships, as well as innovative technological product launches to expand their business product portfolio as main strategies. There is a sturdy growth in the production as new companies are entering the leukapheresis market. For example, in May 2017, a leading medical devices company, Fresenius (Germany), announced its expanded production for medical devices in Haina, Dominican Republic (US). The Haina plant manufactures and exports apheresis systems for plasma and platelet collection as well as medical devices for blood separation. In the leukapheresis market, Terumo BCT (US) holds the leadership position due to advancing surgical innovation, production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions. In 2018, the company has adopted new product launches, product enhancements, and geographic expansion as its crucial business plans to certify its dominance in this market. The objective of the report is to present comprehensive analysis of leukapheresis market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding leukapheresis market dynamics, structure by analyzing the market segments, and project the leukapheresis market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the leukapheresis market make the report investor’s guide.
Leukapheresis Market Scope: Inquiry Before Buying
Global Leukapheresis Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 65.78 Bn. Forecast Period 2023 to 2029 CAGR: 7.5 % Market Size in 2029: US $ 109.13 Bn. Segments Covered: by Type Leukapheresis Devices Apheresis Devices Leukapheresis Columns & Cell Separators Leukoreduction Filters Leukapheresis Disposables by Application Research Applications Therapeutic Applications by End User Blood Component Providers and Blood Centers Academic and Research Institutes Pharmaceutical and Biotechnology Companies Hospitals and Transfusion Centers Leukapheresis Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Leukapheresis Market Key Players:
1. Asahi Kasei Medical 2. Haemonetics 3. Terumo BCT 4. STEMCELL Technologies 5. Macopharma 6. Fresenius 7. Hema Care 8. Caltag Medsystem 9. All Cells 10.StemExpress 11.PPA Research Group 12.Key Biologics 13.ZenBio 14.Precision for Medicine 15.BioIVT 16.Key Biologics LLC 17.Miltenyi Biotec 18.Guangzhou Daji Medical Science and Technology Co. Ltd. 19.MEDICA S.p.A 20.PuriBlood Medical Co. Ltd. 21.Beijing ZKSK Technology Co. Ltd. *List Not Exhaustive Frequently Asked Questions: 1. Which region has the largest share in Global Leukapheresis Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Leukapheresis Market? Ans: The Global Leukapheresis Market is growing at a CAGR of 7.5 % during forecasting period 2023-2029. 3. What is scope of the Global Leukapheresis market report? Ans: Global Leukapheresis Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Leukapheresis market? Ans: The important key players in the Global Leukapheresis Market are –Asahi Kasei Medical, Haemonetics, Terumo BCT, STEMCELL Technologies, Macopharma, Fresenius, HemaCare, Caltag Medsystem, AllCells, StemExpress, PPA Research Group, Key Biologics, ZenBio, Precision for Medicine, BioIVT, Key Biologics LLC, Miltenyi Biotec, Guangzhou Daji Medical Science and Technology Co. Ltd., MEDICA S.p.A, PuriBlood Medical Co. Ltd., Beijing ZKSK Technology Co. Ltd., and *List Not Exhaustive 5. What is the study period of this market? Ans: The Global Leukapheresis Market is studied from 2022 to 2029.
1. INTRODUCTION 1.1 Report Description 1.1.1 Objectives of the Study 1.1.2 Market Scope 1.1.3 Years considered in the study 1.1.4 Currency 1.1.5 Stakeholders 1.2 Target Audience 1.3 Key Takeaways 2. RESEARCH METHODOLOGY 2.1 Research Methodology 2.2 Market Definition 2.3 Assumptions and Acronyms Used 2.4 Data Sources 2.4.1 Secondary 2.4.1.1 Paid 2.4.1.2 Unpaid 2.4.2 Primary 2.5 Analyst tools and models 3. EXECUTIVE SUMMARY 3.1 Leukapheresis Market Overview 3.1.1 Leukapheresis Market : By Type 3.1.2 Leukapheresis Market : By Application 3.1.3 Leukapheresis Market : By End users 3.1.4 Leukapheresis Market : By Region 4. LEUKAPHERESIS MARKET OUTLOOK 4.1 Leukapheresis Market : Market Definition, Segmentation and Scope of Study 4.2 Leukapheresis Market : Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Leukapheresis Market : Competitive Analysis 4.3.1 Key Strategic Initiatives 4.3.2 Regional Presence 4.3.3 Product Overview 4.4 Leukapheresis Market : Porter’s Analysis 4.5 Leukapheresis Market : PESTEL Analysis 4.6 Leukapheresis Market : Product Benchmark Analysis 4.7 Leukapheresis Market : Company Market Share Analysis 4.8 Leukapheresis Market : Key Findings 4.8.1 Leukapheresis Market : Top Wining Strategies 4.8.2 Leukapheresis Market : Top Investment Pockets 4.8.3 Leukapheresis Market : Top Impacting Factors 5. LEUKAPHERESIS MARKET, BY TYPE 5.1 Leukapheresis Market : Type segment Market Share analysis 5.2 Leukapheresis Market : Type segment Market Size and Forecast 2022-2029 5.3 Leukapheresis Market by Leukapheresis Devices 5.4 Leukapheresis Market by Leukapheresis Disposables 5.5 Leukapheresis Market Benchmarking By Type 5.6 Leukapheresis Market by Type : Key Trends 5.7 Leukapheresis Market by Type : Key Developments 6. LEUKAPHERESIS MARKET , BY APPLICATION 6.1 Leukapheresis Market : application segment Market Share Analysis 6.2 LEUKAPHERESIS MARKET : application segment Market Size and Forecast 2022-2029 6.3 Leukapheresis Market by Research Applications 6.4 Leukapheresis Market by Therapeutic Applications 6.5 Leukapheresis Market Benchmarking By Application 6.6 Leukapheresis Market by Application: Key Trends 6.7 Leukapheresis Market by Application: Key Developments 7. LEUKAPHERESIS MARKET, BY END USERS 7.1 Leukapheresis Market : End users segment Market Share analysis 7.2 Leukapheresis Market : End users segment Market Size and Forecast 2022-2029 7.3 Leukapheresis Market by Blood Component Providers and Blood Centers 7.4 Leukapheresis Market by Academic and Research Institutes 7.5 Leukapheresis Market by Pharmaceutical and Biotechnology Companies 7.6 Leukapheresis Market by Hospitals and Transfusion Centers 7.7 Leukapheresis Market Benchmarking By End users 7.8 Leukapheresis Market by End users: Key Trends 7.9 Leukapheresis Market by End users: Key Developments 8. LEUKAPHERESIS MARKET , BY GEOGRAPHY 8.1 Leukapheresis Market : Market Share Analysis 8.2 Leukapheresis Market : Market Size and Forecast 2022-2029 8.3 North America 8.3.1 Overview 8.3.2 Leukapheresis Market Size and Forecast, by Type 2022-2029 8.3.3 Leukapheresis Market Share Analysis , by Type 2022-2029 8.3.4 Leukapheresis Market Size and Forecast, by Application 2022-2029 8.3.5 Leukapheresis Market Share Analysis , by Application 2022-2029 8.3.6 Leukapheresis Market Size and Forecast, by End users 2022-2029 8.3.7 Leukapheresis Market Share Analysis , by End users 2022-2029 8.4 Europe 8.4.1 Overview 8.4.2 Leukapheresis Market Size and Forecast, by Type 2022-2029 8.4.3 Leukapheresis Market Share Analysis , by Type 2022-2029 8.4.4 Leukapheresis Market Size and Forecast, by Application 2022-2029 8.4.5 Leukapheresis Market Share Analysis , by Application 2022-2029 8.4.6 Leukapheresis Market Size and Forecast, by End users 2022-2029 8.4.7 Leukapheresis Market Share Analysis , by End users 2022-2029 8.5 Asia Pacific 8.5.1 Overview 8.5.2 Leukapheresis Market Size and Forecast, by Type 2022-2029 8.5.3 Leukapheresis Market Share Analysis , by Type 2022-2029 8.5.4 Leukapheresis Market Size and Forecast, by Application 2022-2029 8.5.5 Leukapheresis Market Share Analysis , by Application 2022-2029 8.5.6 Leukapheresis Market Size and Forecast, by End users 2022-2029 8.5.7 Leukapheresis Market Share Analysis , by End users 2022-2029 8.6 Latin America, Middle East and Africa 8.6.1 Overview 8.6.2 Leukapheresis Market Size and Forecast, by Type 2022-2029 8.6.3 Leukapheresis Market Share Analysis , by Type 2022-2029 8.6.4 Leukapheresis Market Size and Forecast, by Application 2022-2029 8.6.5 Leukapheresis Market Share Analysis , by Application 2022-2029 8.6.6 Leukapheresis Market Size and Forecast, by End users 2022-2029 8.6.7 Leukapheresis Market Share Analysis , by End users 2022-2029 8.7 Leukapheresis Market Benchmarking By Geography 8.8 Leukapheresis Market by Geography : Key Trends 8.9 Leukapheresis Market by Geography : Key Developments 9. COMPITITIVE LANDSCAPE 9.1 Leukapheresis Market Share/ Positioning Analysis 9.2 Leukapheresis Market: Key Innovators 9.3 Leukapheresis Market : Company Profiles 9.3.1 Asahi Kasei Medical 9.3.1.1 Overview 9.3.1.2 Product/Service Portfolio 9.3.1.3 Key Financials 9.3.1.4 Strategic Initiatives 9.3.1.5 SWOT Analysis 9.3.1.6 Competitive Assessment 9.3.2 Haemonetics 9.3.2.1 Overview 9.3.2.2 Product/Service Portfolio 9.3.2.3 Key Financials 9.3.2.4 Strategic Initiatives 9.3.2.5 SWOT Analysis 9.3.2.6 Competitive Assessment 9.3.3 Terumo BCT 9.3.3.1 Overview 9.3.3.2 Product/Service Portfolio 9.3.3.3 Key Financials 9.3.3.4 Strategic Initiatives 9.3.3.5 SWOT Analysis 9.3.3.6 Competitive Assessment 9.3.4 STEMCELL Technologies 9.3.4.1 Overview 9.3.4.2 Product/Service Portfolio 9.3.4.3 Key Financials 9.3.4.4 Strategic Initiatives 9.3.4.5 SWOT Analysis 9.3.4.6 Competitive Assessment 9.3.5 Macopharma 9.3.5.1 Overview 9.3.5.2 Product/Service Portfolio 9.3.5.3 Key Financials 9.3.5.4 Strategic Initiatives 9.3.5.5 SWOT Analysis 9.3.5.6 Competitive Assessment 9.3.6 Fresenius 9.3.6.1 Overview 9.3.6.2 Product/Service Portfolio 9.3.6.3 Key Financials 9.3.6.4 Strategic Initiatives 9.3.6.5 SWOT Analysis 9.3.6.6 Competitive Assessment 9.3.7 HemaCare 9.3.7.1 Overview 9.3.7.2 Product/Service Portfolio 9.3.7.3 Key Financials 9.3.7.4 Strategic Initiatives 9.3.7.5 SWOT Analysis 9.3.7.6 Competitive Assessment 9.3.8 Caltag Medsystem 9.3.8.1 Overview 9.3.8.2 Product/Service Portfolio 9.3.8.3 Key Financials 9.3.8.4 Strategic Initiatives 9.3.8.5 SWOT Analysis 9.3.8.6 Competitive Assessment 9.3.9 AllCells 9.3.9.1 Overview 9.3.9.2 Product/Service Portfolio 9.3.9.3 Key Financials 9.3.9.4 Strategic Initiatives 9.3.9.5 SWOT Analysis 9.3.9.6 Competitive Assessment 9.3.10 StemExpress 9.3.10.1 Overview 9.3.10.2 Product/Service Portfolio 9.3.10.3 Key Financials 9.3.10.4 Strategic Initiatives 9.3.10.5 SWOT Analysis 9.3.10.6 Competitive Assessment 9.3.11 PPA Research Group 9.3.11.1 Overview 9.3.11.2 Product/Service Portfolio 9.3.11.3 Key Financials 9.3.11.4 Strategic Initiatives 9.3.11.5 SWOT Analysis 9.3.11.6 Competitive Assessment 9.3.12 Key Biologics 9.3.12.1 Overview 9.3.12.2 Product/Service Portfolio 9.3.12.3 Key Financials 9.3.12.4 Strategic Initiatives 9.3.12.5 SWOT Analysis 9.3.12.6 Competitive Assessment 9.3.13 ZenBio 9.3.13.1 Overview 9.3.13.2 Product/Service Portfolio 9.3.13.3 Key Financials 9.3.13.4 Strategic Initiatives 9.3.13.5 SWOT Analysis 9.3.13.6 Competitive Assessment 9.3.14 Precision for Medicine 9.3.14.1 Overview 9.3.14.2 Product/Service Portfolio 9.3.14.3 Key Financials 9.3.14.4 Strategic Initiatives 9.3.14.5 SWOT Analysis 9.3.14.6 Competitive Assessment 9.3.15 BioIVT 9.3.15.1 Overview 9.3.15.2 Product/Service Portfolio 9.3.15.3 Key Financials 9.3.15.4 Strategic Initiatives 9.3.15.5 SWOT Analysis 9.3.15.6 Competitive Assessment 9.3.16 Key Biologics LLC 9.3.17 Miltenyi Biotec 9.3.18 Guangzhou Daji Medical Science and Technology Co. Ltd. 9.3.19 MEDICA S.p.A 9.3.20 PuriBlood Medical Co. Ltd. 9.3.21 Beijing ZKSK Technology Co. Ltd. 10. CONSOLIDATION 10.1 Leukapheresis Market: Mergers and Acquisitions 10.1.1 Overview 10.1.2 Leukapheresis Market : Key Drivers – By Region 10.1.3 Leukapheresis Market : M&A Breakdown 10.1.3.1 Type Based 10.1.3.2 Application Based 10.1.3.3 End Users Based 10.1.3.4 Niche Based 10.1.3.5 Region Based 10.1.3.6 Asset & Non-Asset Based 10.1.3.7 Venture Capitalist Based 10.2 Fragmentation of Leukapheresis Market 10.3 Leukapheresis Market : Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 10.4 Leukapheresis Market - New/Emerging Models of Partnerships : Key Examples 10.5 Leukapheresis Market : New/Emerging Business Models : Key Examples 10.6 Leukapheresis Market - Changing Investment Paradigm : Focused areas by Key Players 10.7 Leukapheresis Market - Patent Analysis 11. Leukapheresis Market : LIST OF TABLES 12. Leukapheresis Market : LIST OF FIGURES